BioPharm International Editors


Researchers from the University of California Riverside Investigate Plant-Based mRNA Vaccines

UCR scientists are researching whether a plant-based messenger RNA vaccine can be created and aim to eliminate the need for the refrigeration of mRNA vaccines during transport and storage.

Health Canada Approves Moderna’s COVID-19 Vaccine, Spikevax, for 12 Years & Up

Health Canada approved the new drug submission for Spikevax—more commonly known as the Moderna COVID-19 vaccine—for active immunization to prevent COVID-19 in individuals 12 years of age and older.

FDA Revises EUA for Use of Bamlanivimab and Etesevimab for Post-Exposure Prophylaxis Prevention for COVID-19

FDA revised the emergency use authorization for bamlanivimab and etesevimab (administered together) to include emergency use as post-exposure prophylaxis (prevention) for COVID-19.

Moderna Releases New Clinical Data on COVID-19 Vaccine

Moderna’s newest insights include an overall efficacy review, a study on breakthrough infections, and a study on long-term immunity.